Representative before the EPO

Employment test 51 - 200 employees
Company dna potter clarkson llp
operating since 1889
Headquarter in Nottingham and 1 office
active in Legal Services, IP Consulting, and IP Portfolio Processing

Philip John Duval Thomas has worked on the following 6 EPO patent applications which have been published in the last five years:

EP12196192

Mutant G-protein coupled receptors and methods for making them

IPC classification:
C07K 14/72, C12N 15/10, G01N 33/566
Agent:
Philip John Duval Thomas, Potter Clarkson LLP
Status:
EXAMINATION IN PROGRESS
EP12192130

Screening

IPC classification:
C07K 14/705, C12N 15/10, G01N 33/543, G01N 33/566
Agent:
Philip John Duval Thomas, Potter Clarkson LLP
Status:
EXAMINATION IN PROGRESS
EP11760261

RNA INTERFERENCE IN DERMAL AND FIBROTIC INDICATIONS

IPC classification:
A61K 31/713, A61P 1/00, A61P 11/00, A61P 13/00, A61P 17/00, A61P 17/02, C07H 21/02
Agent:
Philip John Duval Thomas, Potter Clarkson LLP
Status:
EXAMINATION IN PROGRESS
EP12718715

RE-DIRECTED IMMUNOTHERAPY

IPC classification:
A61K 39/12, A61K 47/48, A61P 37/00
Applicant:
University of Birmingham
Agent:
Philip John Duval Thomas, Potter Clarkson LLP
Status:
PATENT GRANTED
EP12819805

METHODS, COMPOSITIONS AND KITS FOR ASSAYING MITOCHONDRIAL FUNCTION

IPC classification:
C12Q 1/00, C12Q 1/26, C12Q 1/32
Applicant:
University of Massachusetts
Agent:
Philip John Duval Thomas, Potter Clarkson LLP
Status:
PATENT GRANTED
EP11760245

RNA INTERFERENCE IN OCULAR INDICATIONS

IPC classification:
A61K 31/713, A61P 9/10, A61P 27/00, A61P 27/06
Agent:
Philip John Duval Thomas, Potter Clarkson LLP
Status:
EXAMINATION IN PROGRESS

Please Sign in to use this feature